Benjamin Linas, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, New York University School of Medicine
MPH, Harvard School of Public Health




Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Associate Professor
Boston University School of Public Health
Epidemiology





Providence/Boston Center for AIDS Research(CFAR): Core B-Developmental
07/01/2018 - 06/30/2023 (PI)
Miriam Hospital NIH-NIAID

Researching Effective Strategies to Prevent Opioid Death(RESPOND)
06/01/2018 - 03/31/2023 (PI)
NIH-NIDA
1R01DA046527-01

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
09/01/2016 - 07/31/2021 (PI)
Trustees of Columbia University NIH-NIDA

Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health
09/30/2014 - 09/29/2019 (PI)
Harvard School of Public Health CDC

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core B Developmental (Pilot Projects)
07/01/2016 - 06/30/2019 (PI)
Miriam Hospital NIH-NIAID

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health..
07/01/2015 - 04/30/2019 (PI)
Cornell University NIH-NIDA
5P30DA040500-04

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment…
03/01/2018 - 12/31/2018 (PI)
Denver Health and Hospital Authority NIH-NIDA

Health Economics of Substance Abuse and HCV/HIV Treatment in the Era of Integrated Health Care - …
09/01/2017 - 04/30/2018 (PI)
Weill Cornell Medical College NIH-NIDA

Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs
02/15/2015 - 01/31/2018 (PI)
Cornell University NIH-NIDA

Intensive Models of HCV Care for Injection Drug Users
07/15/2012 - 06/30/2017 (PI)
AlbertEinsteinCllgeOfMed of Yeshiva U. NIH-NIDA

Showing 10 of 16 results. Show All Results


Yr Title Project-Sub Proj Pubs
2019 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 5R01DA046527-02
2019 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 3R01DA046527-02S1
2019 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-05-6229 93
2018 Researching Effective Strategies to Prevent Opioid Death (RESPOND) 1R01DA046527-01
2018 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-04-6229 93
2017 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-03-6229 93
2016 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 5P30DA040500-02-6229 93
2015 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 5R01DA031059-04 35
2015 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) 1P30DA040500-01-6229 93
2014 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care 3R01DA031059-03S1 35
Showing 10 of 18 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Jones EA, Linas BP, Truong V, Burgess JF, Lasser KE. Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program. PLoS One. 2019; 14(3):e0213745.View Related Profiles. PMID: 30870475.
     
  2. Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. J Hepatol. 2019 Feb 21.View Related Profiles. PMID: 30797050.
     
  3. Cohen GH, Tamrakar S, Lowe S, Sampson L, Ettman C, Kilpatrick D, Linas BP, Ruggiero K, Galea S. Improved social services and the burden of post-traumatic stress disorder among economically vulnerable people after a natural disaster: a modelling study. Lancet Planet Health. 2019 Feb; 3(2):e93-e101.View Related Profiles. PMID: 30797416.
     
  4. Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, Randall L, Salomon JA, Linas BP. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstet Gynecol. 2019 Feb; 133(2):289-300.View Related Profiles. PMID: 30633134.
     
  5. Tasillo A, Linas BP. Decision Science at Work: The Case of Latent Tuberculosis Screening. Am J Kidney Dis. 2019 Jan; 73(1):8-10. PMID: 30579384.
     
  6. Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE. Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant. Am J Transplant. 2018 Dec 27. PMID: 30589503.
     
  7. Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, Christiansen CL, Linas BP. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States. AIDS. 2018 Nov 28; 32(18):2787-2798.View Related Profiles. PMID: 30234602.
     
  8. Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 Jan; 56(1):8-16.View Related Profiles. PMID: 30467088.
     
  9. Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec; 108(12):1675-1681.View Related Profiles. PMID: 30359112; DOI: 10.2105/AJPH.2018.304673;.
     
  10. Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. Am J Transplant. 2018 Oct; 18(10):2483-2495. PMID: 30058218.
     
Showing 10 of 78 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 78 publications over 17 distinct years, with a maximum of 23 publications in 2018

YearPublications
19961
19971
19981
20002
20062
20082
20093
20101
20112
20121
20132
20149
20155
20167
201711
201823
20195
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Viral Hepatitis Hepatitis C Virus HIV infection Comparative effectiveness Cost-Effectiveness Simulation modeling Data analytics Transmission modeling Health Economics Health Policy
Contact for Mentoring:


Physicians Diagnosing, Treating HCV Define New Role in Opioid Crisis

Healio 7/17/2018

771 Albany St
Boston MA 02118
Google Map

617.414.5238
Download vCard

Linas's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (235) concept(s)
_
Co-Authors
See all (27) people
_
Similar People
See all (60) people
_
Same Department
Search Department